Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy

Reinders, M.E.J.; Roemeling-van Rhijn, M.; Khairoun, M.; Lievers, E.; Vries, D.K. de; Schaapherder, A.F.M.; ... ; Roelofs, H. (2013)

Article / Letter to editor

• autologous
• mesenchymal stromal cells
• transplant recipients

• All authors: Reinders, M.E.J.; Roemeling-van Rhijn, M.; Khairoun, M.; Lievers, E.; Vries, D.K. de; Schaapherder, A.F.M.; Wong, S.W.S.; Zwaginga, J.J.; Duijs, J.M.; Zonneveld, A.J. van; Hoogduijn, M.J.; Fibbe, W.E.; Fijter, J.W. de; Kooten, C. van; Rabelink, T.J.; Roelofs, H.
• Date: 2013-06-30
• Journal: Cytotherapy
• Volume: 15
• Issue: 6
• Pages: 663 - 672
• DOI: doi:10.1016/j.jcyt.2013.01.010